In English | En español
Questions About Cancer? 1-800-4-CANCER

Clinical Trials Search Results

Clinical Trials Search Results

Initial search results include only NCI-sponsored clinical trials. To search all trials, click the "REFINE SEARCH" button, scroll down to the Trial ID/Sponsor section and select the "All" check box in the Sponsor of Trial section.

View Content for:
Display:
  •          
Help with display options.
Results 1-25 of 54 for your search:
Cancer Type/Condition:  Leukemia, acute myeloid (AML), adult
Stage/Subtype:  recurrent adult acute myeloid leukemia
Country:  U.S.A.
Trial Type:  Treatment
Trial Status:  Active
Sponsor of Trial:  NCI
Start Over
        Show
1.

Phase: Phase III
Type: Biomarker/Laboratory analysis, Supportive care, Treatment
Status: Active
Age: not specified
Sponsor: NCI, Other
Protocol IDs: 2448.00, NCI-2010-02035, P30CA015704, P01CA018029, NCT01231412

2.

Phase: Phase II, Phase I
Type: Treatment
Status: Active
Age: 18 to 75
Sponsor: NCI, Other
Protocol IDs: CDR0000447204, P30CA016058, OHSU-HEM-05011-L, OHSU-210, NCT00245037

3.

Phase: Phase II, Phase I
Type: Treatment
Status: Active
Age: Under 55
Sponsor: NCI, Other
Protocol IDs: 06-125, MSKCC-06125, NCT00423514

4.

Phase: Phase II, Phase I
Type: Biomarker/Laboratory analysis, Treatment
Status: Active
Age: 18 to 69
Sponsor: NCI
Protocol IDs: 070195, 07-C-0195, NCI-07-C-0195, NCT00520130

5.

Phase: Phase II, Phase I
Type: Treatment
Status: Active
Age: Any age
Sponsor: NCI, Other
Protocol IDs: 2230.00, NCI-2010-00106, P30CA015704, P01CA078902, FHCRC-2230.00, IR-6771, NCT00789776

6.

Phase: Phase II, Phase I
Type: Biomarker/Laboratory analysis, Treatment
Status: Active
Age: 60 and over
Sponsor: NCI
Protocol IDs: CASE1908, NCI-2009-01285, NCT01093573

7.

Phase: Phase II, Phase I
Type: Biomarker/Laboratory analysis, Treatment
Status: Active
Age: Not specified
Sponsor: NCI, Other
Protocol IDs: 2498.00, NCI-2011-03362, P30CA015704, P01CA018029, NCT01640301

8.

Phase: Phase II, Phase I
Type: Biomarker/Laboratory analysis, Treatment
Status: Active
Age: 18 and over
Sponsor: NCI, Other
Protocol IDs: 2011-204, NCT01643603

9.

Phase: Phase II, Phase I
Type: Treatment
Status: Active
Age: 13 to 60
Sponsor: NCI, Other
Protocol IDs: BMT236, SU-09142011-8407, NCT01660607

10.

Phase: Phase II, Phase I
Type: Biomarker/Laboratory analysis, Treatment
Status: Active
Age: 18 to 75
Sponsor: NCI, Other
Protocol IDs: 2652.00, NCI-2012-02224, P30CA015704, NCT01729845

11.

Phase: Phase II, Phase I
Type: Biomarker/Laboratory analysis, Treatment
Status: Active
Age: 60 to 75
Sponsor: NCI, Other
Protocol IDs: 13-08-148, NCI-2013-02493, P30CA013330, NCT02038153

12.

Phase: Phase II, Phase I
Type: Treatment
Status: Active
Age: 18 and over
Sponsor: NCI, Other
Protocol IDs: 2734.00, NCI-2013-02465, 2734, P30CA015704, NCT02044796

13.

Phase: Phase II
Type: Treatment
Status: Active
Age: 18 and over
Sponsor: NCI, Other
Protocol IDs: 2186.00, NCI-2010-00404, P30CA015704, P01CA044991, FHCRC-2186.00, NCT00589316

14.

Phase: Phase II
Type: Treatment
Status: Active
Age: Any age
Sponsor: NCI, Other
Protocol IDs: 2239.00, NCI-2009-01551, P30CA015704, FHCRC-2239.00, 6722, FHCRC-IR-6722, NCT00723099

15.

Phase: Phase II
Type: Treatment
Status: Active
Age: Under 65
Sponsor: NCI, Other
Protocol IDs: 2275.00, NCI-2010-00299, P30CA015704, FHCRC-2275.00, IR-6800, NCT00796068

16.

Phase: Phase II
Type: Treatment
Status: Active
Age: 18 and over
Sponsor: NCI, Other
Protocol IDs: CDR0000633749, S0919, U10CA032102, SWOG-S0919, NCT00840177

17.

Phase: Phase II
Type: Supportive care, Treatment
Status: Active
Age: 14 to 55
Sponsor: NCI, Other
Protocol IDs: FHCRC-2222.00, P30CA015704, P01CA018029, IR-6907, CDR0000644201, 0903004832, NCT00914940

18.

Phase: Phase II
Type: Biomarker/Laboratory analysis, Treatment
Status: Active
Age: 75 and under
Sponsor: NCI, Other
Protocol IDs: 2212.00, NCI-2009-01244, P30CA015704, U19AI096111, P01CA018029, NCT00968630

19.

Phase: Phase II
Type: Biomarker/Laboratory analysis, Supportive care, Treatment
Status: Active
Age: Not specified
Sponsor: NCI, Other
Protocol IDs: 2206.00, NCI-2010-02222, P30CA015704, P01CA018029, NCT01251575

20.

Phase: Phase II
Type: Biomarker/Laboratory analysis, Treatment
Status: Active
Age: not specified
Sponsor: NCI, Other
Protocol IDs: 2430.00, NCI-2010-02247, P01CA018029, P01CA078902, P30CA015704, NCT01252667

21.

Phase: Phase II
Type: Treatment
Status: Active
Age: 9 to 40
Sponsor: NCI
Protocol IDs: 110136, 11-C-0136, NCT01338987

22.

Phase: Phase II
Type: Biomarker/Laboratory analysis, Treatment
Status: Active
Age: 21 to 69
Sponsor: NCI, Other
Protocol IDs: IRB00007195, 1R21CA159265-01, NCT01620216

23.

Phase: Phase II
Type: Treatment
Status: Active
Age: 6 months and older
Sponsor: NCI, Other
Protocol IDs: J1240, P01CA015396, NA_00072223, NCT01700673

24.

Phase: Phase II
Type: Biomarker/Laboratory analysis, Treatment
Status: Active
Age: 14 to 75
Sponsor: NCI, Other
Protocol IDs: 12-1191, NCI-2013-00782, NCT01839916

25.

Phase: Phase II
Type: Treatment
Status: Active
Age: Any age
Sponsor: NCI, NHLBI
Protocol IDs: 130116, 13-H-0116, NCT01861093
1    
New Search